332 related articles for article (PubMed ID: 25275602)
1. TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion.
Joseph JV; Conroy S; Tomar T; Eggens-Meijer E; Bhat K; Copray S; Walenkamp AM; Boddeke E; Balasubramanyian V; Wagemakers M; den Dunnen WF; Kruyt FA
Cell Death Dis; 2014 Oct; 5(10):e1443. PubMed ID: 25275602
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
[TBL] [Abstract][Full Text] [Related]
3. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
Pang H; Zheng Y; Zhao Y; Xiu X; Wang J
Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542
[TBL] [Abstract][Full Text] [Related]
4. Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition.
Kahlert UD; Maciaczyk D; Doostkam S; Orr BA; Simons B; Bogiel T; Reithmeier T; Prinz M; Schubert J; Niedermann G; Brabletz T; Eberhart CG; Nikkhah G; Maciaczyk J
Cancer Lett; 2012 Dec; 325(1):42-53. PubMed ID: 22652173
[TBL] [Abstract][Full Text] [Related]
5. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway.
Chen W; Kong KK; Xu XK; Chen C; Li H; Wang FY; Peng XF; Zhang Z; Li P; Li JL; Li FC
Int J Oncol; 2018 Feb; 52(2):485-495. PubMed ID: 29345288
[TBL] [Abstract][Full Text] [Related]
7. Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway.
Zhu M; Niu J; Jiang J; Dong T; Chen Y; Yang X; Liu P
Life Sci; 2022 Mar; 293():120358. PubMed ID: 35092731
[TBL] [Abstract][Full Text] [Related]
8. Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-β1/Smad signaling pathway.
Jiang Y; Zhou J; Hou D; Luo P; Gao H; Ma Y; Chen YS; Li L; Zou D; Zhang H; Zhang Y; Jing Z
J Pathol; 2019 Sep; 249(1):26-38. PubMed ID: 30953361
[TBL] [Abstract][Full Text] [Related]
9. miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells.
Chen Y; Xiao Y; Ge W; Zhou K; Wen J; Yan W; Wang Y; Wang B; Qu C; Wu J; Xu L; Cai W
Cell Death Dis; 2013 Mar; 4(3):e541. PubMed ID: 23492772
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.
Yamamoto H; Mukaisho K; Sugihara H; Hattori T; Asano S
Biol Pharm Bull; 2011; 34(3):324-9. PubMed ID: 21372379
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
12. ZEB1 limits adenoviral infectability by transcriptionally repressing the coxsackie virus and adenovirus receptor.
Lacher MD; Shiina M; Chang P; Keller D; Tiirikainen MI; Korn WM
Mol Cancer; 2011 Jul; 10():91. PubMed ID: 21791114
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA linc00645 promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma.
Li C; Zheng H; Hou W; Bao H; Xiong J; Che W; Gu Y; Sun H; Liang P
Cell Death Dis; 2019 Sep; 10(10):717. PubMed ID: 31558707
[TBL] [Abstract][Full Text] [Related]
14. LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.
Du X; Tu Y; Liu S; Zhao P; Bao Z; Li C; Li J; Pan M; Ji J
J Cell Mol Med; 2020 Jan; 24(2):1474-1487. PubMed ID: 31856394
[TBL] [Abstract][Full Text] [Related]
15. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.
Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A
Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-10b mediates TGF-β1-regulated glioblastoma proliferation, migration and epithelial-mesenchymal transition.
Ma C; Wei F; Xia H; Liu H; Dong X; Zhang Y; Luo Q; Liu Y; Li Y
Int J Oncol; 2017 May; 50(5):1739-1748. PubMed ID: 28393237
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
18. Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.
Choi YJ; Baek GY; Park HR; Jo SK; Jung U
PLoS One; 2016; 11(1):e0147343. PubMed ID: 26799321
[TBL] [Abstract][Full Text] [Related]
19. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.
Larsen JE; Nathan V; Osborne JK; Farrow RK; Deb D; Sullivan JP; Dospoy PD; Augustyn A; Hight SK; Sato M; Girard L; Behrens C; Wistuba II; Gazdar AF; Hayward NK; Minna JD
J Clin Invest; 2016 Sep; 126(9):3219-35. PubMed ID: 27500490
[TBL] [Abstract][Full Text] [Related]
20. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
